Abstract
Follicular variant of papillary thyroid carcinoma (FVPTC) creates a continuous diagnostic dilemma among pathologists because of the paucity of nuclear changes of papillary carcinoma and overlapping features with benign and other neoplastic follicular lesions. Current guidelines for the management of thyroid nodules recommend surgery for confirmed PTC, suspicious for PTC, and follicular neoplasm cases, while further immediate diagnostic studies or treatment are not routinely required if the nodule is benign on cytology. This study is designed to determine the accuracy of cytology in the diagnosis of FVPTC, based on the Bethesda classification system, and determine the implications for patient management based on the current recommendation. Based on a retrospective review of cytologic diagnoses between January 2008 and December 2011, thyroid fine needle aspiration (FNA) cytology specimens with subsequent surgical intervention and a final diagnosis of FVPTC were selected. The cytologic diagnoses were compared with the final diagnoses, and the percentage of cases contributing to the final diagnosis of FVPTC was calculated for each diagnostic category. Triage efficiency and diagnostic accuracy were calculated. One hundred and fifty-two cases with histologic confirmation of FVPTC were identified (representing 128 patients—101 female, 27 male). All patients had undergone either lobectomy with completion thyroidectomy or total thyroidectomy. The cytologic diagnosis of “positive for malignancy” accounted for only 27 % of the final histologic diagnosis of FVPTC, while suspicious for carcinoma, follicular neoplasm, follicular lesion of undetermined significance, and benign accounted for 11, 23, 23, and 16 % of the final diagnosis of FVPTC, respectively. Only 18 % of the 55 cases tested were positive for BRAF mutation. The subtle nuclear features of FVPTC pose challenges for an accurate diagnosis. Therefore, a better approach is to triage these cases for surgical intervention and/or further evaluation of the particular nodule. Our triage efficacy for FVPTC was 84 %; however, the diagnostic accuracy of PTC was 38 %. A negative diagnosis on FNA has diagnostic and management implications for up to 16 % of cases because they may have no further immediate diagnostic studies or treatment. BRAF mutation analysis provides minimal effect on diagnostic accuracy.
Similar content being viewed by others
References
Ramacciotti CE, Pretorius HT, Chu EW, et al. Diagnostic accuracy and use of aspiration biopsy in the management of thyroid nodules. Arch Intern Med 144:1169–1173, 1984.
Wang HH Reporting thyroid fine needle aspiration: Literature review and a proposal. Diagn Cytopathol 34:67–76, 2006.
Adeniran AJ, Zhu Z, Gandhi M, et al. Correlation between genetic alterations and microscopic features, clinical manifestations, and prognostic characteristics of thyroid papillary carcinomas. Am J Surg Pathol 30:216–222, 2006.
Lam AK, Lo CY, Lam KS. Papillary carcinoma of thyroid: A 30-yr clinicopathological review of the histological variants. Endocrine Pathol 16:323–30,2005.
Kesmodel SB, Terhune KP, Canter RJ, et al. The diagnostic dilemma of follicular variant of papillary thyroid carcinoma. Surgery 134:1005–1012, 2003.
Shih SR, Shun CT, Su DH, et al. Follicular variant of papillary thyroid carcinoma: Diagnostic limitations of fine needle aspiration cytology. Acta Cytol 49:383–386, 2005.
Lin HS, Komisar A, Opher E, Blaugrund SM. Follicular variant of papillary carcinoma: the diagnostic limitations of preoperative fine-needle aspiration and intraoperative frozen section evaluation. Laryngoscope 110:1431–1436, 2000.
Caraway NP, Sneige N, Samaan NA. Diagnostic pitfalls in thyroid fine-needle aspiration: a review of 394 cases. Diagn Cytopathol 9:345–50, 1993.
Powari M, Dey P, Saikia UN. Fine needle aspiration cytology of follicular variant of papillary carcinoma of thyroid. Cytopathology 14:212–215, 2003.
Yang J, Schnadig V, Logrono R, Wasserman PG. Fine-needle aspiration of thyroid nodules: A study of 4703 patients with histologic and clinical correlations. Cancer 111:306–315, 2007.
Miller JM, Hamburger JI, Kini SR. The needle biopsy diagnosis of papillary thyroid carcinoma. Cancer 48:989 –993, 1981.
Salajegheh A, Petcu EB, Smith RA, Lam AK. Follicular variant of papillary thyroid carcinoma: a diagnostic challenge for clinicians and pathologists. Postgrad Med J 84:78–82, 2008.
El Hag IA, Kollur SM. Benign follicular thyroid lesions versus follicular variant of papillary carcinoma: Differentiation by architectural pattern. Cytopathology 15:200–205, 2004.
Zacks JF, de las Morenas A, Beazley RM, O’Brien MJ. Fine-needle aspiration cytology diagnosis of colloid nodule versus follicular variant of papillary carcinoma of the thyroid. Diagn Cytopathol 18:87–90, 1998.
Wu HH, Jones JN, Grzybicki DM, Elsheikh TM. Sensitive cytologic criteria for the identification of follicular variant of papillary thyroid carcinoma in fine-needle aspiration biopsy. Diagn Cytopathol 29:262–266, 2003.
Williams MD, Suliburk JW, Staerkel GA, et al. Clinical significance of distinguishing between follicular lesion and follicular neoplasm in thyroid fine-needle aspiration biopsy. Ann Surg Oncol 16:3146–3153, 2009.
Jogai S, Adesina AO, Temmim L, et al. Follicular variant of papillary thyroid carcinoma—A cytological study. Cytopathology 15:212–216, 2004.
Dobrinja C, Trevisan G, Liguori G, et al. Sensitivity evaluation of fine-needle aspiration cytology in thyroid lesions. Diagn Cytopathol 37:230–235, 2009.
Tielens ET, Sherman SI, Hruban RH, Ladenson PW. Follicular variant of papillary thyroid carcinoma. A clinicopathologic study. Cancer 73:424–31, 1994.
Lin HW, Bhattacharyya N. Clinical behavior of follicular variant of papillary thyroid carcinoma: presentation and survival. Laryngoscope 120:712–716, 2010.
Chang HY, Lin JD, Chou SC, et al. Clinical presentations and outcomes of surgical treatment of follicular variant of the papillary thyroid carcinomas. Jpn J Clin Oncol 36:688–693, 2006.
Lang BH, Lo CY, Chan WF, et al. Classical and follicular variant of papillary thyroid carcinoma: a comparative study on clinicopathologic features and long-term outcome. World J Surg 30:752–758, 2006.
Jain M, Khan A, Patwardhan N, et al. Follicular variant of papillary thyroid carcinoma: A comparative study of histopathologic features and cytology results in 141 patients. Endocr Pract 7:79–84, 2001.
Logani S, Gupta PK, LiVolsi VA, et al. Thyroid nodules with FNA cytology suspicious for follicular variant of papillary thyroid carcinoma: follow-up and management. Diagn Cytopathol 23:380–385, 2000
Cooper DS, Doherty GM, Haugen BR, et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16:109–142, 2006
Baloch ZW, Cibas ES, Clark DP, et al. The National Cancer Institute Thyroid fine needle aspiration state of the science conference: A summation. Cytojournal 5:6, 2008
Theoharis CG, Schofield KM, Hammers L, et al. The Bethesda thyroid fine-needle aspiration classification system: year 1 at an academic institution. Thyroid 19:1215–1223, 2009.
Baloch ZW, Fleisher S, LiVolsi VA, Gupta PK. Diagnosis of “follicular neoplasm”: A gray zone in thyroid fine-needle aspiration cytology. Diagn Cytopathol 26:41–44, 2002.
Yang GC, Goldberg JD, Ye PX. Risk of malignancy in follicular neoplasms without nuclear atypia statistical analysis of 397 thyroidectomies. Endocr Pract 9:510–516, 2003.
Raber W, Kaserer K, Niederle B, Vierhapper H. Risk Factors for Malignancy of Thyroid Nodules Initially Identified as Follicular Neoplasia by Fine-Needle Aspiration: Results of a Prospective Study of One Hundred Twenty Patients. Thyroid 10:709–712, 2000.
Marhefka GD, McDivitt JD, Shakir KM, Drake AJ 3rd Diagnosis of follicular neoplasm in thyroid nodules by fine needle aspiration cytology: does the result, benign vs. suspicious for a malignant process, in these nodules make a difference? Acta Cytol. 53:517–523, 2009.
Fu L, Chhieng D, Theoharis C, et al. Impact of Second Review of Thyroid FNA on the Implementation of Bethesda Classification: An Analysis of Cases on a Consult Service. Modern Pathol. 26(S2):89A, 2013.
Yoon JH, Kim E, Hong SW, et al. Sonographic features of the follicular variant of papillary thyroid carcinoma. J Ultrasound Med 27:1431–1437, 2008.
Gupta S, Ajise O, Dultz L, et al. Follicular variant of papillary thyroid cancer, encapsulated, non-encapsulated and diffuse: Distinct biologic and clinical entities. Arch Otolaryngol Head Neck Surg. 138:227–233, 2012.
Proietti A, Giannini R, Ugolini C, et al. BRAF status of follicular variant of papillary thyroid carcinoma and its rela\tionship to its clinical and cytological features. Thyroid 20:1263–1270, 2010.
Fadda G, Rossi ED, Raffaelli M, et al. Follicular thyroid neoplasms can be classified as low- and high-risk according to HBME-1 and Galectin-3 expression on liquid-based fine-needle cytology. Eur J Endocrinol. 165:447–453, 2011.
Cochand-Priollet B, Dahan H, Laloi-Michelin M, et al. Immunocytochemistry with cytokeratin 19 and anti-human mesothelial cell antibody (HBME1) increases the diagnostic accuracy of thyroid fine-needle aspirations: preliminary report of 150 liquid-based fine-needle aspirations with histological control. Thyroid. 21:1067–1073, 2011.
Rossi ED, Raffaelli M, Minimo C, et al. Immunocytochemical evaluation of thyroid neoplasms on thin-layer smears from fine-needle aspiration biopsies. Cancer. 105:87–95, 2005
Funding
This study was supported by funding from the Department of Pathology, Yale University School of Medicine, New Haven, CT.
Financial Disclosures
The authors have no financial disclosures.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ustun, B., Chhieng, D., Prasad, M.L. et al. Follicular Variant of Papillary Thyroid Carcinoma: Accuracy of FNA Diagnosis and Implications for Patient Management. Endocr Pathol 25, 257–264 (2014). https://doi.org/10.1007/s12022-014-9301-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12022-014-9301-3